Pregled bibliografske jedinice broj: 1157553
Regulation of KRAS protein expression by miR-544a and KRAS-LCS6 polymorphism in wild-type KRAS sporadic colon adenocarcinoma
Regulation of KRAS protein expression by miR-544a and KRAS-LCS6 polymorphism in wild-type KRAS sporadic colon adenocarcinoma // Human Cell, 34 (2021), 5; 1455-1465 doi:10.1007/s13577-021-00576-2 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1157553 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Regulation of KRAS protein expression by miR-544a
and KRAS-LCS6 polymorphism in wild-type KRAS
sporadic colon adenocarcinoma
Autori
Marinović, Sonja ; Škrtić, Anita ; Catela Ivković, Tina ; Poljak, Mirko ; Kapitanović, Sanja
Izvornik
Human Cell (1749-0774) 34
(2021), 5;
1455-1465
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Colon adenocarcinoma ; Immunohistochemistry ; KRAS ; let-7a ; miR-544a
Sažetak
Colorectal carcinoma (CRC) results from the accumulation of genetic mutations and alterations in signaling pathways. KRAS is mutated in 40% of CRC cases and is involved in increased tumor cells proliferation and survival. Although KRAS mutations are a dominant event in CRC tumorigenesis, increased wild-type KRAS expression has a similar efect on accelerated tumor growth. In this study, we investigated the KRAS status in correlation with clinicopathological features in sporadic CRC and more importantly the role of let- 7a-5p and miR- 544a-3p in the regulation of wild- type KRAS protein expression in the tumor center (T1) and invasive tumor front (T2). Analysis showed that 39.1% of tumor samples had KRAS mutations. In wild-type KRAS tumors, 62.0% were positive for KRAS protein expression and there was a higher percentage of KRAS-positive tumor cells and a higher intensity of immunohistochemical reaction in T2 than in T1 samples. This could not be attributed to differences in KRAS mRNA levels, suggesting regulation via miR-544a-3p expression which was signifcantly decreased in T2 samples. Furthermore, we demonstrated that tumor samples carrying the KRAS-LCS6 variant allele had signifcantly higher protein expression of the wild-type KRAS. Our results suggest the role of the KRAS-LCS6 polymorphism and miR-544a-3p expression in the regulation of wild-type KRAS protein expression in sporadic CRC.
Izvorni jezik
Engleski
Znanstvena područja
Biologija, Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
HRZZ-IP-2016-06-1430 - Mikrosatelitna nestabilnost (MSI i EMAST) u molekularnom profiliranju sporadičnih karcinoma debelog crijeva (MSIandEMASTinCRC) (Kapitanović, Sanja, HRZZ - 2016-06) ( CroRIS)
Ustanove:
Klinička bolnica "Merkur",
Institut "Ruđer Bošković", Zagreb
Profili:
Sanja Kapitanović
(autor)
Sonja Marinović
(autor)
Tina Catela Ivković
(autor)
Anita Škrtić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE